Top Searches
May 16, 2012
| eCliniqua > Trial Designs



Industry Trends

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More

Trial Design


Change page: < >  |  Displaying page 1 of 3, items 1 to 10 of 28.

Orphan Drug Research Suddenly in Vogue: Aug 16 Orphan Drug Research Suddenly in Vogue: Aug 16

DIA: Innovation, Issues-Driven, Upbeat DIA: Innovation, Issues-Driven, Upbeat

Most Approved Drugs Tested Overseas

Jun 23 | New York Times | The inspector general of the HHS released a report stating that 80% of the drugs approved for sale in 2008 had trials in foreign countries and 78% of all subjects that participated in clinical trials were enrolled at foreign sites.

Early Trial Planning Solutions & DIA News: Jun 21 Early Trial Planning Solutions & DIA News

A Social Approach to Patient Recruitment A Social Approach to Patient Recruitment

Choosing Countries for Oncology Trials

Jun 3 | News Brief | Premier Research Group has released a white paper that reviews a funnel-approach to selecting target countries for oncology trials

FDA's New PRO Guidance Highlights Patient's Perspective: May 17 FDA’s New PRO Guidance Highlights Patient’s Perspective: May 17

Integrating InForm EDC at Dana-Farber Cancer Institute Integrating InForm EDC at Dana-Farber Cancer Institute

BioClinica Acquires Cephalon's U.S. Data Management Team BioClinica Acquires Cephalon’s U.S. Data Management Team

Mayo Clinic Backs First Independent Clinical Trials: Apr 5 Mayo Clinic Backs First Independent Clinical Trials

White Papers & Special Reports

More White Papers & Special Reports
Life Science Webcasts & Podcasts

medidata_podcast_Sites and Sponsors: Mending Bridges over Troubled Waters  
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide

This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.

• Common ground in reaching agreement on a budget

• Improving the pace of agreement on budgets and contracts

• Processes for payment to sites on a timely basis

Listen Now 

More Podcasts

Job Openings

Firmenich
PhD COMPUTATIONAL SYSTEMS SCIENTIST
To review full job description please go to www.Firmenich.com and search for Computational Biologist. All qualified candidates send updated resume to ppapiccio@agile1.com.
read more
abbott labs
Abbott Labs, Health Informatics Program ManagerQualified candidates may apply by posting their resume to www.abbott.com/careers. Reference number: 110844BR.
read more




Sponsored Links

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .